Asymmetric Biocatalytic Synthesis of Fluorinated Pyridines through Transesterification or Transamination: Computational Insights into the Reactivity of Transaminases by López Iglesias, María et al.
 1 
 FULL PAPER 
DOI: 10.1002/adsc.201((will be filled in by the editorial staff)) 
Asymmetric biocatalytic synthesis of fluorinated pyridines through 
transesterification or transamination. Computational insights into the 
reactivity of transaminases. 
María López-Iglesias,a,b Daniel González-Martínez,a María Rodríguez-Mata,a Vicente 
Gotor,a Eduardo Busto,c,* Wolfgang Kroutilb,* and Vicente Gotor-Fernándeza,* 
a Departamento de Química Orgánica e Inorgánica, Instituto Universitario de Biotecnología de Asturias, Universidad de 
Oviedo, 33006 Oviedo, Spain. Telephone: +34985103454; Fax number: +34985103446. E-mail: vicgotfer@uniovi.es 
b Department of Chemistry, Organic and Bioorganic Chemistry, University of Graz, NAWI Graz, BioTechMed Graz, 
Heinrichstraβe 28, 8010 Graz, Austria. Telephone: +433163805350; Fax number: +433163809840. E-mail: 
wolfgang.kroutil@uni-graz.at.  
c Departamento de Quı́mica Orgánica I, Facultad de Quı́mica, Universidad Complutense de Madrid, 28040 Madrid, 
Spain. Telephone: +34913944231; Fax number: +34913944103. E-mail: bbusto@ucm.es 
Received: ((will be filled in by the editorial staff)) 
Supporting information for this article is available on the WWW under http://dx.doi.org/10.1002/adsc.201######. 
Abstract. The synthesis of a family of pyridines bearing a 
fluorinated substituent on the aromatic ring has been carried 
out through two independent and highly stereoselective 
chemoenzymatic strategies. Short chemical synthetic routes 
toward fluorinated racemic amines and prochiral ketones 
have been developed, which served as substrates to explore 
the suitability of lipases and transaminases in asymmetric 
biotransformations. The lipase-catalyzed kinetic resolution 
via acylation of racemic amines proceeded smoothly giving 
conversions close to 50% and excellent enantioselectivities. 
Alternatively, the biotransamination of the corresponding 
prochiral ketones was investigated giving access to both 
optically pure amine enantiomers using transaminases with 
complementary selectivity. High to quantitative 
conversion values were achieved, which allowed the 
isolation of the amines in moderate to high yields (40-
88%).  
A deeper understanding of the latter process was enabled 
by performing theoretical calculations on thermodynamic 
and mechanistic aspects. Calculations showed that the 
biotransamination reactions are highly favoured by the 
presence of fluorine atoms and the pyridine ring. 
Keywords: Amines; Asymmetric synthesis; Biocatalysis; 
Computational chemistry; Organofluorinated compounds; 
Pyridines 
Introduction 
The synthesis of organofluorine compounds has 
received great attention in recent years due to their 
uses in different scientific areas.1 Fluorinated 
organic molecules possess a wide range of 
applications as agrochemicals,2 pharmaceuticals,3 
and asymmetric catalysts.4 In a rough estimation, 
around 20% pharmaceuticals and 40% agrochemicals 
contain at least one fluorine atom in their structure.5 
The incorporation of fluorine in organic molecules 
may lead to important changes in their stability, 
bioavailability and binding affinity to receptors.6 
The fluorine presence can significantly affect their 
physicochemical properties such as acidity, 
hydrogen-bonding, lipophilicity, solubility and 
biological properties,7 improving metabolic stability 
and making possible the discovery of new drug 
candidates.8 In this context, the development of 
heterocyclic systems bearing fluorinated 
functionalities opens up the access to new valuable 
molecules.9 
Biocatalytic methodologies have been described 
for the production of biologically active 
organofluorine molecules through selective 
halogenation using halogenases.10 Alternatively, the 
asymmetrization of prochiral or racemic starting 
materials allows the access to enantiopure fluorinated 
compounds by using other classes of enzymes such as 
alcohol dehydrogenases,11 hydrolases12 or 
transaminases.13 
Chiral amines are interesting and versatile 
compounds with great appeal in both academic and 
industrial fields.14 This structural motif is nowadays 
considered as an interesting scaffold in the 
preparation of bioactive molecules.15 In this context, 
the development of stereoselective biocatalytic 
methods toward optically active amines has attracted 
increasing attention in recent years.16 The present 
work combines the relevance that chiral amines offer 
and the potential of compounds bearing fluorine 
atoms, as both are challenging items for the scientific 
community. Hence, a series of pyridylethanamine 
enantiomers containing a fluorine atom or a 
trifluoromethyl group at the 5- or 6-position of the 
heteroaromatic ring have been stereoselectively 
synthesized by two independent enzymatic 
approaches: (a) lipase-catalyzed kinetic resolution via 
transesterification or (b) highly efficient asymmetric 
amination employing transaminases. 
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Scheme 1. Synthesis of ketones 3a-c and racemic amines 4a-c for the study of its enzymatic amination or kinetic 
resolution, respectively. 
Results and Discussion 
The synthetic pathway has been chosen in accordance 
with the availability of the commercial substrates as 
well as the viability of the chemical process. Racemic 
amines 4a and 4b bearing fluorine atoms at 5- or 6-
position of the pyridine ring were synthesized in 
moderate yields via a two-step hydroxyalkylation of 
the corresponding 5-bromopyridines 1a and 1b, 
respectively (Scheme 1, top). A subsequent chemical 
oxidation of the resulting racemic alcohols 2a and 2b 
using the Dess-Martin reagent in dichloromethane 
allowed the isolation of the ketones 3a and 3b (85-
95% isolated yield). Then, these ketones were 
submitted to a classical reductive amination 
employing sodium cyanoborohydride and ammonium 
acetate in methanol. In the particular case of the 
trifluoromethylated derivative 4c, the alternative 
pathway compromises only two steps: first, addition 
of methylmagnesium iodide to the cyano group of the 
commercially available 6-
(trifluoromethyl)nicotinonitrile (5) and, secondly, the 
reductive amination of the so-obtained ketone 3c 
(Scheme 1, bottom). These methodologies for 
racemic amine syntheses are useful for further 
application in enzymatic reactions. On the one hand, 
the three racemates will serve as both substrates for 
lipase-catalyzed transformations and final products 
for analytical purposes in biotransamination 
experiments. On the other hand, the intermediate 
ketones will be the substrates in transaminase-
catalyzed reactions. 
Once completed the synthesis of the ketones 3a-c 
and amines 4a-c, two stereoselective enzymatic 
strategies were studied: the classical kinetic 
resolution through lipase-catalyzed enantioselective 
acylation of the racemic amines 4a-c and, 
alternatively, the amination of prochiral ketones 3a-c 
using transaminases. 
Asymmetric synthesis through lipase-catalyzed 
resolutions 
The potential of lipases in the acylation of racemic 
amines has been broadly studied as an efficient 
strategy for the synthesis of enantiopure amines in 
organic solvents under mild reaction conditions.16c,17 
On this basis, the classical kinetic resolution of the 
fluorinated 1-(pyridin-3-yl)ethanamines 4a-c was 
attempted. The initial reaction conditions were 
rationally established according to the following 
remarks. First of all, Candida antarctica lipase B 
(CAL-B, Novozyme 435) was selected as suitable 
biocatalyst due to the good results reported in 
literature on structurally similar substrates.18 Ethyl 
methoxyacetate was chosen as acylating agent due to 
the excellent selectivity and activity values displayed 
in the resolution of racemic amines.19 THF was 
preferred as solvent owing to solubility issues, using 
a 100 mM substrate concentration for the study 
(Table 1). 
Table 1. CAL-B-catalyzed kinetic resolution of racemic 
amines 4a-c through enantioselective acylation.a 
Entry 4a-c t 
(h) 
eeS 
(%)b 
eeP 
(%)b 
c 
(%)c 
Ed 
1 a (5-F) 7 90 >99 47 >200 
2 b (6-F) 2 96 >99 49 >200 
3 c (6-CF3) 3 94 >99 49 >200 
a Reaction conditions: racemic amine 4a-c (100 mM) in 
THF, ethyl methoxyacetate (5 equiv) and a ratio of 
substrate: CAL-B 1:1 (w/w) at 30 ºC and 250 rpm. 
b Determined by HPLC on a chiral column by analysing 
the methoxyacetamides or the corresponding acetamides 
obtained after derivatization of the enantioenriched amines 
(see Supporting Information). 
c c = ees/(ees + eep). 
d E= ln[(1-c)(1-eep)]/ln[(1-c)(1+eep)].20 
Enzymatic reactions took place with excellent 
enantioselectivity for all the three tested substrates, 
and conversions reached almost the maximum 50% 
value in short reaction times (2-7 h, Table 1, entries 
1-3). Thus, this methodology afforded the 
enantiopure methoxyacetamides (R)-6a-c and the 
remaining amines (S)-4a-c in up to 96% ee. Control 
experiments were performed revealing that CAL-B 
was undoubtedly responsible of the catalysis. Amide 
formation was not detected in the absence of enzyme, 
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which was expected based on the excellent 
selectivities observed in all cases. 
Asymmetric synthesis through biotransamination 
In the pursuit of enzymatic strategies that led to 
theoretically 100% yield processes toward optically 
active amines, transaminases (TAs) were chosen as 
alternative biocatalysts.16b,21 This option allowed to 
take advantage of the synthetic pathway previously 
described, as the ketones 3a-c, which are now 
substrates for transamination experiments, were 
indeed prepared as intermediates in the synthesis of 
the amines 4a-c studied in lipase-catalyzed acylations. 
Thus, a number of representative transaminases 
overexpressed in E. coli were considered, working at 
a 50 mM substrate concentration (Table 2). These 
transaminases are the (S)-selective from Vibrio 
fluvialis,22 Chromobacterium violaceum23 and 
Arthrobacter citreus,24 and the (R)-selective from 
Arthrobacter sp.25 and its evolved variant called 
ArRmut1126 used as semipurified form by a heat 
treatment (see Experimental section). 
According to the biocatalyst tolerance, alanine 
(system a) or an excess of 2-propylamine (1 M, 
system b) were selected as amino source, including in 
the first case a pyruvate removal system formed by 
NAD+/ammonium formate/alanine dehydrogenase 
(AlaDH)/formate dehydrogenase (FDH) working in 
parallel with the main reaction. Despite the important 
differences detected in reactivity depending on both 
the transaminase and the substrate, it is noteworthy 
the excellent enantioselectivity obtained in all cases 
for the production of amines 4a-c (>99% ee). 
 
Table 2. Asymmetric biotransamination of ketones 3a-c using different amino sources.a 
 
Entry 3a-c TA System c (%)b eeP (%)c 
1 a (5-F) Vibrio fluvialis (a) 89 >99 (S) 
2 a (5-F) Chromobacterium violaceum (a) 80 >99 (S) 
3 a (5-F) Arthrobacter citreus (a) 36 >99 (S) 
4 a (5-F) Arthrobacter sp. (a) 85 >99 (R) 
5 a (5-F) Semipurified ArRmut11 (b) 69 >99 (R) 
6 b (6-F) Vibrio fluvialis (a) 26 >99 (S) 
7 b (6-F) Chromobacterium violaceum (a) 45 >99 (S) 
8 b (6-F) Arthrobacter citreus (a) <1 n.m. 
9 b (6-F) Arthrobacter sp. (a) 75 >99 (R) 
10 b (6-F) Semipurified ArRmut11 (b)   6 n.m. 
11 c (6-CF3) Vibrio fluvialis (a) 69 >99 (S) 
12 c (6-CF3) Chromobacterium violaceum (a) 80 >99 (S) 
13 c (6-CF3) Arthrobacter citreus (a) 36 >99 (S) 
14 c (6-CF3) Arthrobacter sp. (a) 94 >99 (R) 
15 c (6-CF3) Semipurified ArRmut11 (b) 85 >99 (R) 
a Reaction conditions in system a: phosphate buffer (100 mM, pH 7), ketone 3a-c (50 mM), lyophilized cells E. coli/TA 
(20 mg), PLP (1 mM), NAD+ (1 mM), L- or D-alanine (250 mM), AlaDH (10 µL, 11 U), FDH (2.6 mg, 11 U), ammonium 
formate (150 mM), 24 h at 30 ºC and 120 rpm. Reaction conditions in system b: phosphate buffer (100 mM, pH 7), ketone 
3a-c (50 mM), semipurified ArRmut11-TA (500 µL), PLP (0.5 mM), 2-propylamine (1 M), 24 h at 45 ºC and 120 rpm. 
b Conversion values were determined by GC analysis after isolation of products by extraction from basified media (see 
Experimental section). 
c Enantiomeric excess values were measured by GC on a chiral column after the in situ derivatization with acetic 
anhydride of the resulting amines (see Supporting Information). n.m.: not measured. 
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Table 3. Asymmetric biotransamination of ketones 3a-c using alanine dehydrogenase system and performing a 
rehydration step of the TA before its use in the enzymatic reaction.a 
Entry 3a-c TA c (%)b eeP (%)c 
1 a (5-F) Vibrio fluvialis 90 >99 (S) 
2 a (5-F) Chromobacterium violaceum 99 (71) >99 (S) 
3 a (5-F) Arthrobacter sp. 99 (79) >99 (R) 
4 b (6-F) Chromobacterium violaceum 88 (40)d >99 (S) 
5 b (6-F) Arthrobacter sp. 92 >99 (R) 
6 c (6-CF3) Chromobacterium violaceum >99 >99 (S) 
7 c (6-CF3) Arthrobacter sp. >99 (88) >99 (R) 
a Reaction conditions: lyophilized cells E. coli/TA (20 mg) rehydrated in phosphate buffer (100 mM, pH 7) for 30 min at 
30 ºC and 120 rpm, ketone 3a-c (50 mM), PLP (1 mM), NAD+ (1 mM), L- or D-alanine (250 mM), AlaDH (10 µL, 11 U), 
FDH (2.6 mg, 11 U), ammonium formate (150 mM), 24 h at 30 ºC and 120 rpm. 
b Conversion values were determined by GC analysis after isolation of products by extraction in basified media (see 
Experimental section). Isolated yields in parentheses. 
c Enantiomeric excess values were measured by GC on a chiral column after an in situ derivatization with acetic 
anhydride of the resulting amines (see Supporting Information). 
d A further purification step by column chromatography was performed in order to separate the product from the 
unreacted ketone. 
Starting with ketone 3a, good conversion values 
were observed in the formation of the amine (S)-4a 
with the TAs from Vibrio fluvialis and 
Chromobacterium violaceum (Table 2, entries 1 and 
2), while the TA from Arthrobacter citreus only led 
to a 36% conversion (Table 2, entry 3). For the (R)-
selective enzymes a 85% conversion was obtained 
with the TA from Arthrobacter sp. (Table 2, entry 4), 
and 69% with the system b and the mutant 
ArRmut11-TA (Table 2, entry 5). In all cases, the 
amine 4a was isolated in enantiopure form. 
When ketone 3b bearing a fluorine atom 
substituting 6-position of the aromatic ring was 
subjected to enzymatic transamination, a significant 
decrease in reactivity was noticed (Table 2, entries 6-
10). The TA from Chromobacterium violaceum is 
linked to the best results within the (S)-selective 
enzymes (Table 2, entry 7), achieving low to 
moderate conversion values in all the cases (Table 2, 
entries 6-8), whereas for the (R)-selective TAs (Table 
2, entries 9 and 10) the Arthrobacter sp. allowed the 
formation of the enantiopure amine (R)-4b with a 
notable 75% conversion (Table 2, entry 9). 
Remarkably, the more hindered 6-trifluoromethylated 
pyridine 3c showed an enhanced reactivity displaying 
a similar trend as that observed for substrate 3a. Thus, 
excellent conversions were achieved with the (R)-
Arthrobacter leading to the amine (R)-4c in 
enantiopure form (94%, Table 2, entry 14), and the 
Chromobacterium violaceum TA allowed the 
formation of the counterpart (S)-4c in a good extent 
(80%, Table 2, entry 12). 
These promising results led us to make some 
adjustments in the reaction conditions in the belief 
that an improvement in conversions could be 
achieved by increasing the substrate solubility, a 
parameter identified as key factor of the process. 
However, the presence of water-miscible organic 
cosolvents did not cause significant improvement on 
the amine formation (Table S1), and even lower 
conversions were observed when alanine was used as 
amine donor (Table S2). A similar behaviour was 
found when the amount of enzyme was doubled, even 
when the presence of too many immiscible solids in 
the reaction medium was avoided by employing cell 
free extract enzymes obtained after breaking cell 
walls by sonication cycles of the enzymatic crude 
(Table S3). 
Having obtained some good results but not fully 
satisfactory ones, we decided to alter the enzyme 
performance by introducing an initial enzyme 
rehydration step. Therefore, the TA and the buffer 
were shaken at 30 °C and 120 rpm for 30 min prior to 
their use in the biotransamination experiments (Table 
3). We were pleased to see a significant improvement 
of conversion values, some of the substrates 
displaying even 99% conversions as for 3a and 3c 
using both (S)- and (R)-selective transaminases 
(Table 3, entries 2 and 3 for 3a, 6 and 7 for 3c). This 
rehydration step enhanced the reactivity for the 
fluorine-substituted ketone 3b as well (Table 3, 
entries 4 and 5), keeping intact the exquisite 
enantioselectivity in all cases. 
With the best results in hand, preparative scale 
biotransformations were performed employing these 
optimized conditions. When TAs from 
Chromobacterium violaceum and Arthrobacter sp. 
were employed, enantiopure amine (S)-4a as well as 
the antipode (R)-4a were successfully isolated in 
good yields (71% and 79%, respectively, entries 2 
and 3) just by performing a basic extraction after 
completion of the reaction. Similarly, the 
Arthrobacter sp. TA provided the amine (R)-4c in 
enantiopure form and very high isolated yield (88%, 
entry 7). While the 1H-NMR analysis of the crude 
reaction mixture revealed high purity for amines (S)-
4a, (R)-4a and (R)-4c, the biotransamination reaction 
of ketone 3b with Chromobacterium violaceum TA 
did not proceed to completion, so a column 
chromatography purification was necessary to 
separate the unreacted ketone 3b from the 
enantiopure amine (S)-4b. In the latest case only a 
40% yield was obtained. 
Next, absolute configurations were assigned 
through circular dichroism (CD) spectroscopy 
analyses. A structurally related compound to the 
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family of pyridines studied here, 1-(pyridin-3-
yl)ethan-1-amine (4d), whose optical rotation values 
are already reported in literature27 was chosen as 
reference. Firstly, optically active (S)- and (R)-4d 
were isolated by carrying out a 50-mg scale up of the 
enzymatic transamination employing the 
Chromobacterium violaceum and Arthrobacter sp. 
TAs, respectively. Then, CD experiments were 
performed observing a negative minimum at 265.6 
nm for (S)-4d and a positive maximum for its 
counterpart (R)-4d at 264.2 nm (Figure 1, left). 
Qualitative comparison of the CD spectra measured 
for both enantiomers of reference pyridine 4d with 
the corresponding spectra of the unknown pyridines 
4a-c (Figure 1, right) allowed us to confirm their 
absolute configuration, which is in agreement either 
with the transaminases expected selectivity and the 
Kazlauskas´ rule28 for the optically active amines 
obtained through lipase-catalyzed reactions. 
At this point all the amines 4a-c have been isolated 
with excellent enantiomeric excess, but still no 
quantitative transformations have been developed for 
all the substrates, something that is significant 
enough to cause a decrease in the isolated yield of the 
6-F-substituted amine 4b. For that reason, we decided 
to deeper investigate the biotransamination of 3a-c 
based on computational calculations. The 
thermochemical study highlights substantial 
differences in the thermodynamic stabilization of the 
fluorinated pyridines, which are reflected in the 
calculated ΔG of the amination reaction for the 
different ketone/amine pairs at the M06-2X/6-
311++G(3df,2p) level (Scheme 2, top). The values 
revealed that the global equilibrium using 
isopropylamine as amine donor is shifted toward the 
amine formation for 4a and 4c derivatives, while for 
pyridine 4b this was found to be unfavourable (see 
additional information in Table S8). Interestingly, a 
relative energy difference of 7.5 kJ/mol was found 
between 5-F and 6-F substituted pyridines (3a and 3b, 
respectively) in the transamination reaction. 
Furthermore, the thermodynamic study was 
extended for the structurally analogues 
acetophenones 3e-g (Scheme 2, bottom), the amine 
formation being in all cases less favourable in 
comparison with the corresponding pyridine pairs 3a-
c. The influence of the nitrogen atom was 
experimentally confirmed in the biotransamination of 
3g employing both 2-isopropylamine and alanine as 
amine donors, which led to moderate conversions that 
are far from the values obtained for the corresponding 
pyridine 3c (Tables S4 and S5, respectively). We 
have recently reported a similar tendency of 
stabilization by the pyridine ring in comparison with 
benzene derivatives, in this case due to the formation 
of an intramolecular hydrogen bond.29 
In our interest in having a deep knowledge of the 
process, key intermediates of the known reaction 
mechanism in the Chromobacterium violaceum TA 
active site were also analyzed through different 
computational approaches (Figures S2 and S3).30 
The ketimine and aldimine intermediates were 
selected for the study of each substrate, which is 
covalently bonded to the PLP cofactor (Figure 2, left). 
Initially, docking experiments were performed 
using the AutoDock software (Figures S4, see 
Supporting Information for details)31 finding in the 
most stable conformations of the intermediates the 
pyridoxal ring located at the crystallographic position 
(Figure 2, right). 
 
Figure 1. CD spectra recorded for reference compounds (S)- and (R)-4d (left), and enantiopure amines (R)-4a, (S)-4b and 
(R)-4c (right) obtained through selected biotransamination reactions. Optical rotation values for amines 4a-c in >99% ee: 
D20 = +36.2 (c 0.5, CHCl3) for (R)-4a; D20 = -28.2 (c 0.5, CHCl3) for (S)-4b; D20 = +20.0 (c 0.5, CHCl3) for (R)-4c. 
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Scheme 2. Global Gibbs free reaction energy in the transamination of ketones 3a-c,e-g and 2-propylamine calculated at 
the M06-2X/6-311++G(3df,2p) level. 
  
Figure 2. Key intermediates in the transamination mechanism (left); and the crystallographic position of the PLP in 
complex with Lys288 (light blue) and the docked conformations of the aldimines and ketimines in the active site of 
Chromobacterium violaceum TA with substitutions: 5-F (A-dark blue; K-purple), 6-F (A-yellow; K-orange) and 6-CF3 (A-
red; K-green). 
The ONIOM(M06-2X/6-31G(d,p):Amber) method 
was employed to optimize the active site geometries 
of each docked intermediate (Figures S5 and S6), 
after which a non covalent interaction analysis was 
carried out with NCIPLOT32 in order to highlight the 
main interactions between the pyridines and the 
closest residues of the TA active site (Figure S7). 
The previous model of the active site was 
employed for a new DFT calculation at the M06-
2X/6-31G(d,p) level of theory in order to obtain the 
wavefunction of the optimized geometry and perform 
a frequency computation (Figure S8 and Table S6). 
The non-covalent interactions around the substrate 
were computed with NCIPLOT using the SCF 
densities (Figure S9 and Table S7). Figure 3 shows 
the enlargement of the zone where the most 
representative non covalent interactions where found 
for each substrate, appearing the weak attractive 
interactions in green, while the strongest ones are 
shown in blue. The difference of energy between the 
two intermediates within the active site was found to 
be favourable for the ketimine in 3a (-11.2 kJ/mol) 
and 3c (-6.0 kJ/mol), which is in agreement with the 
results reported by Cassimjee et al. for acetophenone 
transamination.30 On the contrary, the aldimine of 3b 
was more stable than the corresponding ketimine, 
with an energy difference of 18.9 kJ/mol. 
The nitrogen of the 5-F substituted pyridine forms 
a strong hydrogen bond with the indole N-H of 
tryptophan 60 (Figures 3A-B), which is also present 
on the 6-F substituted pyridine but displaying a 
slightly weaker bond strength (Figure 3C-D). 
Specifically, the hydrogen bond distances and angles 
are 2.16 Å and 159.3 º for the 5-F-aldimine (Figure 
3A), being the values 2.32 Å and 156.5 º in the case 
of the 6-F-aldimine (Figure 3C). On the other hand, 
the distances are shorter in both the ketimine 
structures with values of 2.01 Å (159.3 º) and 2.10 Å 
(154.4 º) for the 5-F and 6-F derivatives, respectively 
(Figures 3B and 3D). Besides, the 6-F-aldimine 
shows an additional N-H···F bond with the arginine 
416 (2.11 Å, 169.3 º), which could be responsible of 
the higher stabilization of the aldimine over the 
ketimine mentioned before. 
Interestingly, the pyridine hydrogen bond is not 
observed in the hindered nitrogen atom of the 6-CF3 
aldimine derivative (Figure 3E) and it is weak in the 
corresponding ketimine derivative (2.54 Å, Figure 
3F), while a new strong interaction between two 
fluorine atoms and the Arg416 is responsible of these 
intermediates stabilization. Thus, three N-H···F 
bonds were found in the aldimine between the two 
fluorine atoms mentioned before and two hydrogens 
of the residue (2.18 Å, 146.4 º; 2.08 Å, 143.1 º; 2.02 
Å, 136.0 º; Figure 3E). For the corresponding 
ketimine (Figure 3F), non-hydrogen bond strong 
electrostatic interactions were established between 
the guanidinium cation and the trifluoromethyl group. 
Despite the differences between the dispositions of 
the three studied substrates, all of them showed 
favourable interactions that enabled the 
transamination reaction smoothly within the active 
site of the TA from Chromobacterium violaceum. On 
the other hand, in contrast with our previous 
investigation with a set of pyridylalkylamines,29 in 
the present work the hydrogen bonds were 
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established to be intermolecular between the intermediate species and key active site residues. 
 
Figure 3. Non-covalent interaction analyses of the optimized geometry within the Chromobacterium violaceum TA active 
site of the aldimines with substitutions (A) 5-F; (C) 6-F; (E) 6-CF3; and the ketimines with substitutions (B) 5-F; (D) 6-F; 
(F) 6-CF3. Non-covalent attractive interactions appear in green (weak) or blue (strong) and the repulsive ones in 
red. Substrates are shown in ball-and-stick representation while the cofactor and the enzyme residues are shown 
as sticks. 
Conclusion 
Enzymes have been used in the asymmetric key-step 
for the synthesis of valuable fluorinated amines. The 
development of a straightforward synthetic pathway 
led to suitable substrates for lipase and transaminase-
catalyzed transformations, which has made possible 
the preparation of a family of optically active 
pyridylethanamines bearing a fluorine atom at 5- or 
6-position, or a trifluoromethyl group at 6-position. 
On the one hand, classical kinetic resolutions 
through Candida antarctica lipase B-catalyzed 
acylation reached conversions close to the ideal 50%. 
Both the methoxyacetamides and the remaining 
amines were obtained with excellent 
enantioselectivity under mild reaction conditions in 
tetrahydrofuran as solvent. On the other hand, the use 
of transaminases acting with complementary 
stereoselectivity in biotransamination experiments 
allowed the synthesis of both amine enantiomers with 
excellent conversions and complete selectivity in all 
cases. Therefore, the desired enantiopure amines 
were isolated in moderate to good yields. 
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Transamination reactions have been investigated in 
depth in order to get a better understanding of the 
biocatalytic process through computational studies of 
the global equilibrium shift and the main interactions 
in the enzymatic active site. Thus, calculations 
confirmed that the presence of both the fluorine and 
the pyridyl nitrogen of the studied structures favoured 
the stabilization of the intermediates in the active site 
of the Chromobacterium violaceum TA through 
different non covalent interactions and therefore 
promoting the transamination reaction. 
Experimental Section 
Enzyme activity 
Candida antarctica lipase type B (CAL-B, Novozym 435, 
73000 PLU/g) was kindly donated by Novozymes. TAs 
from Chromobacterium violaceum (2.1 U/mg), Vibrio 
fluvialis (1.3 U/mg), Arthrobacter citreus (0.9 U/mg) and 
Arthrobacter species (2.2 U/mg) were overexpressed in 
E.coli and used as lyophilized cells, while the evolved TA 
ArRmut11 (16 U/mg) was overexpressed in E.coli and 
purified by a heat protocol. See supporting Information for 
further details. 
General procedure for the synthesis of the alcohols 2a 
and 2b. 
A 1.6 M solution of nBuLi in n-hexane (1.76 mL, 2.81 
mmol) was added dropwise to a solution of the 
corresponding bromopyridine 1a or 1b (450.5 mg, 2.56 
mmol) in anhydrous Et2O (13 mL) at -78 ºC under argon 
atmosphere. The mixture was stirred at that temperature for 
30 min. Then, a solution of acetaldehyde (360 μL, 6.39 
mmol) in anhydrous Et2O (1 mL) was slowly added to the 
resulting yellow suspension maintaining the inert 
atmosphere. The resulting solution was stirred at -78 ºC for 
additional 1.5 h. After this time, H2O (10 mL) was added, 
leading to an orange suspension that was allowed to reach 
room temperature. Then, an aqueous HCl 1 M solution was 
added until pH 8 and the product was extracted with Et2O 
(8 x 10 mL). The organic layers were combined, dried over 
Na2SO4, filtered and the solvent removed by distillation 
under reduced pressure. The reaction crude was purified by 
column chromatography on silica gel (80% 
EtOAc/Hexane) to afford the alcohols 2a and 2b as yellow 
oils (48-68%). 
1-(5-Fluoropyridin-3-yl)ethan-1-ol (2a). Light yellow 
oil-solid. 48% Yield. 1H NMR (300.13 MHz, CDCl3):  
1.40 (d, 3JHH = 6.5 Hz, 3H, H2), 4.86 (q, 3JHH = 6.5 Hz, 1H, 
H1), 5.05 (brs, 1H, OH), 7.41 (dt, 3JFH = 9.3 Hz, 4JHH = 2.2 
Hz, 1H, H4’), 8.12 (d, 4JHH = 2.6 Hz, 1H, H6’), 8.18 (s, 1H, 
H2’) ppm. 13C NMR (75.5 MHz, CDCl3):  25.3 (CH3, C2), 
66.9 (CH, C1), 120.4 (d, 2JFC = 18.3 Hz, CH, C4’), 136.4 (d, 
2JFC = 24.0 Hz, CH, C6’), 142.8 (d, 4JFC = 3.6 Hz, CH, C2’), 
144.0 (d, 3JFC = 2.5 Hz, C, C3’), 159.8 (d, 1JFC = 258.1 Hz, 
C, C5’) ppm. HRMS (ESI+, m/z): calcd for (C7H9FNO)+ 
(M+H)+: 142.0663, found: 142.0674. 
1-(6-Fluoropyridin-3-yl)ethan-1-ol (2b). Light yellow 
oil-solid. 68% Yield. 1H NMR (300.13 MHz, CDCl3):  
1.45 (d, 3JHH = 6.5 Hz, 3H, H2), 3.46 (brs, 1H, OH), 4.90 (q, 
3JHH = 6.5 Hz, 1H, H1), 6.86 (dd, 3JHH = 8.4 Hz, 3JFH = 2.7 
Hz, 1H, H5’), 7.80 (dt, 3JHH = 8.1 Hz, 4JFH = 8.1 Hz, 4JHH = 
2.5 Hz, 1H, H4’), 8.06 (s, 1H, H2’) ppm. 13C NMR (75.5 
MHz, CDCl3):  25.3 (CH3, C2), 67.2 (CH, C1), 109.5 (d, 
2JFC = 36.9 Hz, CH, C5’), 139.0 (d, 3JFC = 8.0 Hz, CH, C4’), 
139.1 (d, 4JFC = 4.4 Hz, C, C3’), 144.7 (d, 3JFC = 14.2 Hz, 
CH, C2’), 162.9 (d, 1JFC = 238.9 Hz, C, C6’) ppm. HRMS 
(ESI+, m/z): calcd for (C7H9FNO)+ (M+H)+: 142.0663, 
found: 142.0660. 
General procedure for the synthesis of the ketones 3a 
and 3b. 
Dess-Martin reagent (2.65 g, 6.25 mmol) was added to a 
solution of the corresponding alcohols 2a or 2b (0.589 g, 
4.17 mmol) in CH2Cl2 (42 mL). The mixture was stirred at 
room temperature for 2 h. After this time, the reaction was 
quenched by adding an aqueous NaHCO3/Na2S2O3 solution 
(20 mL, 1:1 v/v of aqueous saturated solutions) and stirred 
for additional 5 min until complete disappearance of the 
solid. The mixture was extracted with CH2Cl2 (3 x 20 mL), 
the organic layers were combined, dried over Na2SO4, 
filtered and the solvent removed by distillation under 
reduced pressure to afford the ketones 3a and 3b as yellow 
solids (85-95%). 
1-(5-Fluoropyridin-3-yl)ethan-1-one (3a). Yellow 
solid. 85% Yield. Mp: 48-50 ºC. 1H NMR (300.13 MHz, 
CDCl3):  2.64 (s, 3H, H2), 7.90 (ddd, 3JFH = 8.7 Hz, 4JHH = 
2.8 Hz, 4JHH = 1.7 Hz, 1H, H4’), 8.63 (d, 4JHH = 2.7 Hz, 1H, 
H6’), 8.96 (s, 1H, H2’) ppm. 13C NMR (75.5 MHz, CDCl3): 
 27.1 (CH3, C2), 121.8 (d, 2JFC = 18.7 Hz, CH, C4’), 133.7 
(C, C3’), 142.4 (d, 2JFC = 23.6 Hz, CH, C6’), 145.7 (d, 4JFC = 
4.0 Hz, CH, C2’), 159.6 (d, 1JFC = 259.4 Hz, C, C5’), 195.4 
(C, C1) ppm. HRMS (ESI+, m/z): calcd for (C7H7FNO)+ 
(M+H)+: 140.0506, found: 140.0510. 
1-(6-Fluoropyridin-3-yl)ethan-1-one (3b). Yellow 
solid. 95% Yield. Mp: 47-49 ºC. 1H NMR (300.13 MHz, 
CDCl3):  2.62 (s, 3H, H2), 7.02 (dd, 3JHH = 8.5 Hz, 3JFH = 
2.6 Hz, 1H, H5’), 8.36 (ddd, 3JHH = 8.5 Hz, 4JFH = 7.7 Hz, 
4JHH = 2.6 Hz, 1H, H4’), 8.80 (d, 4JHH = 2.4 Hz, 1H, H2’) 
ppm. 13C NMR (75.5 MHz, CDCl3):  26.8 (CH3, C2), 
110.1 (d, 2JFC =37.3 Hz, CH, C5’), 131.1 (d, 4JFC =4.4 Hz, 
C, C3’), 141.3 (d, 3JFC = 9.4 Hz, CH, C4’), 149.5 (d, 3JFC = 
16.4 Hz, CH, C2’), 165.7 (d, 1JFC = 246.4 Hz, C, C6’), 195.0 
(C, C1) ppm. HRMS (ESI+, m/z): calcd for (C7H7FNO)+ 
(M+H)+: 140.0506, found: 140.0512. 
Procedure for the synthesis of 1-(6-
Trifluoromethyl)pyridine-3-yl)ethan-1-one (3c). 
A 3 M solution of methylmagnesium iodide in Et2O (2.4 
mL, 7.34 mmol) was added dropwise to a solution of the 
carbonitrile 5 (317 mg, 1.84 mmol) in anhydrous Et2O 
(6.11 mL) at 0 ºC and under nitrogen atmosphere. An extra 
millilitre of anhydrous Et2O was added to drag out the 
organomagnesium reagent remaining in the addition funnel, 
and the mixture was stirred at room temperature for 4 h. A 
colour change was observed from the starting yellow 
solution to an intense dark red one during this time. The 
reaction was poured into a saturated aqueous NH4Cl 
solution (6 mL) at 0 ºC and HCl conc. was added until 
strong acid medium (pH 1). The resulting mixture was 
stirred overnight at room temperature and then basified 
until pH 9 by addition of an aqueous NH3 solution. The 
reaction was extracted with Et2O (3 x 15 mL), the 
combined organic layers were dried over Na2SO4, filtered 
and the solvent removed by distillation under reduced 
pressure. The crude product was purified by column 
chromatography on silica gel (20% EtOAc/Hexane) to 
afford the ketone 3c as a pale yellow solid (153 mg, 44%). 
Mp: 57-59 ºC. 1H NMR (300.13 MHz, CDCl3):  2.69 (s, 
3H, H2), 7.81 (d, 3JHH = 8.0 Hz, 1H, H5’), 8.40 (dd, 3JHH = 
8.1 Hz, 4JHH = 1.6 Hz, 1H, H4’), 9.17 (d, 4JHH = 1.3 Hz, 1H, 
H2’) ppm. 13C NMR (75.5 MHz, CDCl3):  27.1 (CH3, C2), 
120.7 (d, 4JFC = 2.5 Hz, CH, C5’), 121.2 (q, 1JFC = 274.6 Hz, 
C, CF3), 134.0 (C, C3’), 137.3 (CH, C4’), 150.0 (CH, C2’), 
151.3 (q, 2JFC = 35.2 Hz, C, C6’), 195.6 (C, C1) ppm. 
HRMS (ESI+, m/z): calcd for (C8H7F3NO)+ (M+H)+: 
190.0474, found: 190.0479. 
General procedure for the synthesis of the racemic 
amines 4a-c. 
Ammonium acetate (335 mg, 4.34 mmol) and sodium 
cyanoborohydride (55 mg, 0.87 mmol) were added to a 
solution of the corresponding ketone 3a-c (0.43 mmol) in 
anhydrous MeOH (1.4 mL). The resulting mixture was 
stirred during 14 h at room temperature. After this time, 
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the solvent was removed by distillation under reduced 
pressure and the reaction crude was purified by column 
chromatography on silica gel (5% MeOH/CH2Cl2), 
yielding the corresponding racemic amines 4a-c (40-55%) 
as yellow oils. 
1-(5-Fluoropyridin-3-yl)ethan-1-amine (4a). Yellow 
oil. 47% Yield. 1H NMR (300.13 MHz, CDCl3):  1.38 (d, 
3JHH = 6.6 Hz, 3H, H2), 1.82 (bs, 2H, NH2), 4.21 (q, 3JHH = 
6.6 Hz, 1H, H1), 7.45 (dt, 3JFH = 9.6 Hz, 4JHH = 2.0 Hz, 1H, 
H4’), 8.32 (d, 4JHH = 2.8 Hz, 1H, H6’), 8.38 (t, 4JHH = 1.8 Hz, 
1H, H2’) ppm. 13C NMR (75.5 MHz, CDCl3):  25.8 (CH3, 
C2), 48.6 (CH, C1), 120.3 (d, 2JFC = 18.1 Hz, CH, C4’), 
136.7 (d, 2JFC = 23.4 Hz, CH, C6’), 143.9 (d, 4JFC = 3.7 Hz, 
CH, C2’), 144.8 (C, C3’), 159.9 (d, 1JFC = 256.5 Hz, C, C5’) 
ppm. HRMS (ESI+, m/z): calcd for (C7H10FN2)+ (M+H)+: 
141.0823, found: 141.0823. 
1-(6-Fluoropyridin-3-yl)ethan-1-amine (4b). Yellow 
oil. 55% Yield. 1H NMR (300.13 MHz, CDCl3):  1.39 (d, 
3JHH = 6.6 Hz, 3H, H1), 1.94 (brs, 2H, NH2), 4.38 (1H, H1), 
6.88 (dd, 3JHH = 8.5 Hz, 3JFH = 2.5 Hz, 1H, H5’), 7.83 (dt, 
3JHH = 8.1 Hz, 4JFH = 8.1 Hz, 4JHH = 2.5 Hz, 1H, H4’), 8.16 
(d, 4JHH = 2.0 Hz, 1H, H2’) ppm. 13C NMR (75.5 MHz, 
CDCl3):  21.2 (CH3, C2), 48.1 (CH, C1), 110.0 (d, 2JFC = 
37.5 Hz, CH, C5’), 140.0 (C, C3’), 140.1 (d, 3JFC = 8.1 Hz, 
CH, C4’), 146.6 (d, 3JFC = 14.8 Hz, CH, C2’), 163.5 (d, 1JFC 
= 240.2 Hz, C, C6’) ppm. HRMS (ESI+, m/z): calcd for 
(C7H10FN2)+ (M+H)+: 141.0823, found: 141.0835. 
1-(6-Trifluoromethyl)pyridine-3-yl)ethan-1-amine 
(4c). Yellow oil. 40% Yield.  1H NMR (300.13 MHz, 
CDCl3):  1.41 (d, 3JHH = 6.6 Hz, 3H, H2), 4.27 (q, 3JHH = 
6.6 Hz, 1H, H1), 7.63 (d, 3JHH = 8.1 Hz, 1H, H5’), 7.90 (dd, 
3JHH = 8.1 Hz, 4JHH = 2.0 Hz, 1H, H4’), 8.68 (d, 4JHH = 2.0 
Hz, 1H, H2’) ppm. 13C NMR (75.5 MHz, CDCl3):  22.2 
(CH3, C2), 48.8 (CH, C1), 120.8 (CH, C5’), 121.2 (q, 1JFC = 
274.1 Hz, C, CF3), 136.4 (CH, C4’), 138.8 (C, C3’), 148.2 
(q, C, 2JFC = 35.1 Hz, C6’), 148.9 (CH, C2’) ppm. HRMS 
(ESI+, m/z): calcd for (C8H10F3N2)+ (M+H)+: 191.0791, 
found: 191.0787. 
General procedure for the kinetic resolution of amines 
(±)-4a-c through CAL-B-catalyzed acylation. 
Ethyl methoxyacetate (5 equiv) was added to a suspension 
containing the corresponding racemic amine 4a-c (40 mg) 
and the enzyme (CAL-B, 40 mg) in anhydrous THF (0.1 
M) under inert atmosphere. The reaction was shaken at 30 
ºC and 250 rpm for the necessary time to achieve a good 
kinetic resolution (2-7 h for around 50% conversion, see 
Table 1), following the reaction timecourse by HPLC 
analysis. The enzyme was filtered off, washed with THF (5 
x 1 mL) and the solvent evaporated under reduced pressure. 
The reaction crude was purified by column 
chromatography on silica gel (eluent gradient 5-50% 
MeOH/CH2Cl2), affording the corresponding optically 
active methoxyacetamides (R)-6a-c (6a: 47% yield; 6b: 
31% yield; 6c: 36% yield) and the remaining amines (S)-
4a-c (4a: 14% yield; 4b: 28% yield; 4c: 34% yield). For 
(R)-6a in >99% ee: D20 = +68.9 (c 1, CHCl3). For (R)-
6b in >99% ee: D20 = +61.4 (c 0.5, CHCl3). For (R)-6c 
in >99% ee: D20 = +56.5 (c 1, CHCl3). 
General procedure for the asymmetric transamination 
of ketones 3a-c employing lyophilized cells and alanine 
dehydrogenase as regeneration system. 
The lyophilized cells of E. coli containing overexpressed 
transaminases (20 mg) were suspended in a 100 mM 
phosphate buffer pH 7 (440 μL) and the mixture was 
stirred at 30 ºC and 120 rpm for 30 min. To the resulting 
suspension, the ketones 3a-c (0.05 mmol, 50 mM), 
ammonium formate (100 µL of 1.5 M solution in a 100 
mM phosphate buffer pH 7; final concentration 150 mM), 
alanine (250 µL of 1 M solution in phosphate buffer 100 
mM pH 7; final concentration 250 mM), NAD+ (100 µL of 
10 mM solution in a 100 mM phosphate buffer pH 7; final 
concentration 1 mM), PLP (100 µL of 10 mM solution in a 
100 mM phosphate buffer pH 7; final concentration 1 mM), 
formate dehydrogenase (FDH, 2.6 mg, 11 U) and alanine 
dehydrogenase (AlaDH, 10 µL, 11 U) were successively 
added. D- or L- alanine was used as amine donor 
depending on the (R) or (S)-transaminase selectivity, 
respectively. 
The resulting mixture was shaken at 30 °C and 120 rpm 
for 24 h. After this time, the reaction was quenched by 
adding an aqueous NaOH 4 M solution (400 µL) and 
extracted with EtOAc (3 x 500 µL). The organic phases 
were combined and dried over Na2SO4. The reaction crude 
was analyzed through GC to determine conversion values, 
requiring an in situ derivatization for the measurement of 
the enantiomeric excess. 
General procedure for the asymmetric transamination 
of ketones 3a-c catalyzed by semipurified ArRmut11-
TA. 
Ketones 3a-c (0.05 mmol, 50 mM) were suspended in a 
100 mM phosphate buffer pH 7 (500 µL) containing PLP 
(1 mM; final concentration 0.5 mM) and 2-propylamine (2 
M; final concentration 1 M). Then, semipurified 
ArRmut11-TA (500 µL) was added and the mixture was 
shaken at 45 °C and 120 rpm for 24 h. The reaction was 
quenched by adding aqueous an aqueous NaOH 4 M 
solution (400 µL), extracted with ethyl EtOAc (3 x 500 
µL). The organic phases were combined and dried over 
Na2SO4. Reaction crude was analyzed through GC to 
determine conversion values, requiring an in situ 
derivatization for the measurement of the enantiomeric 
excesses. 
General procedure for the preparative reductive 
amination of ketones 3a-c employing alanine 
dehydrogenase as regeneration system. 
Scale-up was carried out by linear increasing of the reagent 
amounts reported before. Thus, lyophilized cells of E. coli 
containing overexpressed transaminases (144 mg) were 
suspended in a 100 mM phosphate buffer pH 7 (3.8 mL) 
and the mixture was stirred at 30 ºC and 120 rpm for 30 
min. To the resulting suspension the ketones 3a-c (0.36 
mmol, 50 mM), ammonium formate (720 µL of 1.5 M 
solution in a 100 mM phosphate buffer pH 7; final 
concentration 150 mM), alanine (1.8 mL of 1 M solution in 
a 100 mM phosphate buffer pH 7; final concentration 250 
mM), NAD+ (720 µL of 10 mM solution in a 100 mM 
phosphate buffer pH 7; final concentration 1 mM), PLP 
(720 µL of 10 mM solution in a 100 mM phosphate buffer 
pH 7; final concentration 1 mM), FDH (19 mg, 79 U) and 
alanine dehydrogenase (AlaDH, 72 µL, 79 U) were 
successively added. D- or L- alanine was used as amine 
donor depending on the (R) or (S)-transaminase selectivity, 
respectively. 
The resulting mixture was shaken at 30 °C and 120 rpm 
for 24 h. The reaction was quenched by adding an aqueous 
NaOH 4 M solution until pH around 10 and extracted with 
EtOAc (3 x 10 mL). The organic phases were combined, 
dried over Na2SO4, filtered and the solvent removed under 
reduced pressure. Enantiopure amines (S)-4a, (R)-4a and 
(S)-4c were isolated as colourless oils (71-88% yield). A 
further purification by column chromatography on silica 
gel (10% MeOH/CH2Cl2) was performed to isolate 
enantiopure amine (S)-4b as colourless oil (40% yield). For 
(R)-4a in >99% ee: D20 = +36.2 (c 0.5, CHCl3). For (S)-
4b in >99% ee: D20 = -28.2 (c 0.5, CHCl3). For (R)-4c in 
>99% ee: D20 = +20.0 (c 0.5, CHCl3). 
Heat purification protocol for ArRmut11 
Lyophilized E. coli cells containing overexpressed 
enzyme (2 g) were suspended in a 100 mM phosphate 
buffer pH 7 (20 mL) and the suspension was sonicated 
with the following protocol: 1 s pulse; 4 s pause; 2.5 min; 
40% amplitude. The mixture was centrifuged for 20 min at 
18000 rpm and 4 ºC and the supernatant was treated for 30 
min at 50 ºC. After this time the suspension was 
centrifuged again for 20 min at 18000 rpm and 4 ºC and 
the supernatant containing the active enzyme was stored at 
-18 ºC. Protein concentration: 26.7 mg/mL according to 
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Bradford’s assay. Activity (determined for the deamination 
of α-methylbenzylamine with pyruvate): 16 U/mL. 
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